Funding Opportunity Description
The goal of this Request for Applications (RFA) is to support clinical and translational pilot projects relevant to improving health in West Virginia and Appalachia. This RFA focuses on collaborative projects between partner sites across West Virginia.
Applicants are encouraged to meet with the Investigator Development Manager prior to application submission.
Meghan Reeves, MPH email@example.com 304-293-6581
LOI Due Date – March 31, 2018 by 5:00 PM EST
Full Proposal Due Date – May 15, 2018 by 5:00 PM EST
Required Letter of Intent (LOI)
To better serve those applying for West Virginia Clinical and Translational Science Institute pilot project funding, Letters of Intent (LOI) will be required from interested Co-Project Leaders (Co-PLs)/Co-Principal Investigators (Co-PIs). The proposed collaborative projects should address health care needs of West Virginia. Examples include, but are not limited to, the following health care issues:
- Addiction and Resultant Emerging Epidemics (hepatitis C)
- Cardiovascular Disease
- Chronic Lung Disease
The LOI should follow the template found here and include the following sections:
- Cover Page
- Project Abstract
- Proposed Project Description - In one page or less, please describe the rationale and health care issue addressed, proposed project objectives, and potential impact addressed by the proposed study
- NIH Biosketches of both Co-PIs
For all funding cycles, the budget is limited to a maximum of $50,000 in total direct costs for twelve (12) months, with each site submitting similar budget totals. Applicant teams are encouraged to submit proposals with budgets that are approximately equally supported from 2 institutions, however exceptions may be made on a case by case basis.
Compliance Requirements for a Full Proposal
Co-PIs submitting a full proposal in response to this RFA must include CITI certification for investigators conducting research or collecting outcomes with human subjects as well as documentation of IRB protocol submission and/or IACUC protocol submission. Documentation for these requirements should be included in the Appendix of the application. IRB and IACUC approval are not required prior to application submission deadline but must be completed within 30 days of notice of grant award.
For both the LOI as well as the full proposal, PI eligibility is limited to the following:
- A combination of two of the following institutions MU, WVSOM, and WVU (all campuses) should be represented by one Co-PL/Co-PI each on the proposed research team.
- All Co-PIs must hold a faculty appointment or equivalent at the time the award is announced. For the purposes of this RFA, these are individuals who can independently apply for federal or non-federal investigator-initiated, peer-reviewed Research Project Grants (RPG). Individuals holding postdoctoral fellowships or other positions that lack independent status are not eligible to lead West Virginia Health Grant Partnership projects.
- Any Early Stage Investigator (ESI) applicants are required to submit a one page mentoring agreement plan in the proposal appendix.
- Note that Marshall University faculty members MUST hold an appointment in either the School of Medicine or the School of Pharmacy. Other Schools and Colleges at Marshall University are NOT currently eligible for WVCTSI Pilot grants.
Additional Information on Eligibility–Number of Applications
Co-PLs/Co-PIs can only submit one LOI under this RFA. Individuals may serve as co-investigators or project team members on more than one proposal
- The Project lead for Pilot projects may not concurrently have funding from other IDeA Program award mechanisms (e.g. INBRE, COBRE)
- Pilot projects may not overlap with other ongoing WVCTSI-funded projects.
- Faculty named in the WVCTSI organization (i.e. program chairs and key personnel) are restricted from serving as PI on WVCTSI pilot grants, as well as prohibited from having funds directed to their labs or programs. However, such individuals may be included on pilot grants in supportive roles such as Co-Investigators, mentors, and consultants.